Skip to main content
TipRanks
Go Ultimate75% OFF

LIWANLI Innovation Co., Ltd. (3054) AI Stock Analysis

TW:3054

LIWANLI Innovation Co., Ltd.

(TWSE:3054)

Select Model
Rating:71Outperform
Price Target:TWD 60.00â–²(4.90% Upside)
Action:initiatedcoverage
Date:11/10/26

Strong financial performance and attractive valuation are the primary strengths, led by minimal leverage, positive free cash flow, and a low P/E ratio. These advantages are partly offset by weak technical momentum and the inconsistent historical earnings and cash-flow record.

Positive Factors
Revenue Growth and MarginsThe combination of mid-teens revenue growth and strong gross and EBITDA margins indicates effective monetization and meaningful operating profitability in the latest period. If these levels persist, the company can generate internal funds for investment while strengthening resilience and competitive positioning.
Negative Factors
Volatile Operating ProfitabilitySeveral historical operating-loss years indicate that profitability has not yet demonstrated consistent durability across periods. This volatility can make future earnings harder to forecast, weaken confidence in current margins, and increase the risk that weaker operating conditions materially affect results.

LIWANLI Innovation Co., Ltd. (3054) vs. SPDR S&P 500 ETF (SPY)

-50%0%50%100%150%200%250%300%TW:3054+152.32%SPY+10.92%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 4.75B
Dividend Yield
1.40%
Average Volume (3M)
118.59K
Price to Earnings (P/E)
6.3
Beta (1Y)
0.49
Revenue Growth
297.86%
EPS Growth
1345.78%
Country
TW
Employees
360
Sector
General
Sector Strength
55
Industry
Drug Manufacturers - Specialty & Generic

LIWANLI Innovation Co., Ltd. Business Overview & Revenue Model

Company Description

LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and...

LIWANLI Innovation Co., Ltd. Financial Statement Overview

Summary

Very strong balance sheet with minimal debt, improved TTM profitability, and positive free cash flow support a high score. Historical earnings and cash-flow volatility, plus unusually high TTM net income, reduce confidence in sustainability.

Income Statement

72Positive

Balance Sheet

91Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue473.18M125.54M99.16M38.89M33.99M47.81M
Gross Profit279.86M39.11M20.83M15.08M11.39M7.54M
EBITDA152.76M-68.61M-26.48M6.81M-114.11M65.26M
Net Income727.95M158.15M-32.07M5.10M-120.91M45.56M
Balance Sheet
Total Assets2.02B1.14B792.19M834.17M805.93M947.90M
Cash, Cash Equivalents and Short-Term Investments976.32M446.68M337.68M356.41M386.30M511.55M
Total Debt912.00K2.70M1.80M2.64M3.12M3.11M
Total Liabilities185.23M85.54M39.23M50.66M40.57M50.38M
Stockholders Equity1.84B1.06B752.96M783.51M765.36M897.52M
Cash Flow
Free Cash Flow204.66M-75.83M3.66M-50.45M78.09M-63.31M
Operating Cash Flow204.78M-71.78M14.20M-50.34M78.48M-61.13M
Investing Cash Flow-55.08M-29.59M-11.19M-24.00K3.39M45.96M
Financing Cash Flow-64.96M-353.00K-475.00K-469.00K-1.40M-107.53M

LIWANLI Innovation Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:3054 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:3054TW:305471OutperformTWD 4.51B6.33―1.40%297.86%1345.78%
TW:3031TW:303167NeutralTWD 4.72B31.90―3.45%19.33%4.14%
TW:4974TW:497464NeutralTWD 4.55B12.74―6.22%-18.51%-25.78%
TW:8249TW:824963NeutralTWD 4.42B13.41―6.19%-0.40%-105.99%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:4935TW:493552NeutralTWD 3.94B28.75―3.27%-24.80%-49.71%

* General Sector Average

Performance Comparison

0%100%200%TW:3054TW:3031TW:3717TW:4935TW:4974TW:8249Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:3054 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:3054LIWANLI Innovation Co., Ltd.57.2034.48151.77%
TW:3031Bright Led Electronics Corp28.959.4348.27%
TW:3717Excellence Optoelectronics Holding Co., Inc.22.754.5424.95%
TW:4935Global Lighting Technologies Inc.30.55-10.66-25.86%
TW:4974Asia Tech Image Inc.62.70-6.00-8.74%
TW:8249Creative Sensor Inc.33.60-17.16-33.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026